資源描述：
《Antibody Therapeutics in Cancer (2).pdf》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。
1、AntibodyTherapeuticsinCancerMarkX.SliwkowskiandIraMellmanScience341,1192(2013);DOI:10.1126/science.1241145Thiscopyisforyourpersonal,non-commercialuseonly.Ifyouwishtodistributethisarticletoothers,youcanorderhigh-qualitycopiesforyourcolleagues,clients,orcustomersbyc
2、lickinghere.Permissiontorepublishorrepurposearticlesorportionsofarticlescanbeobtainedbyfollowingtheguidelineshere.Thefollowingresourcesrelatedtothisarticleareavailableonlineatwww.sciencemag.org(thisinformationiscurrentasofSeptember13,2013):Updatedinformationandser
3、vices,includinghigh-resolutionfigures,canbefoundintheonlineversionofthisarticleat:onSeptember13,2013http://www.sciencemag.org/content/341/6151/1192.full.htmlAlistofselectedadditionalarticlesontheScienceWebsitesrelatedtothisarticlecanbefoundat:http://www.sciencemag
4、.org/content/341/6151/1192.full.html#relatedThisarticlecites60articles,19ofwhichcanbeaccessedfree:http://www.sciencemag.org/content/341/6151/1192.full.html#ref-list-1www.sciencemag.orgDownloadedfromScience(printISSN0036-8075;onlineISSN1095-9203)ispublishedweekly,e
5、xceptthelastweekinDecember,bytheAmericanAssociationfortheAdvancementofScience,1200NewYorkAvenueNW,Washington,DC20005.Copyright2013bytheAmericanAssociationfortheAdvancementofScience;allrightsreserved.ThetitleScienceisaregisteredtrademarkofAAAS.Antibodiessuccessesha
6、veledtoaplethoraofADCsinclin-REVIEWicaldevelopment(seebelow).Last,therecentapprovalofipilimumabhasAntibodyTherapeuticsinCancerintroducedyetanothertherapeuticstrategyforanticancerantibodies,namelyactiveimmunother-apy(9).IpilimumabblockstheactivityoftheMarkX.Sliwkow
7、skiandIraMellmannegativeregulatorofTlymphocytes,CTLA4,resultingintheactivationofapatient’simmuneInarelativelyshortperiodoftime,monoclonalantibodieshaveenteredthemainstreamofcancerresponsetocancer.Thisexcitingapproachhastherapy.Theirfirstusewasasantagonistsofoncoge
8、nicreceptortyrosinekinases,buttodayalreadydemonstratedlong-term,durablebenefit.monoclonalantibodieshaveemergedaslong-soughtvehiclesforthetargeteddeliver
